BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27599995)

  • 1. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
    Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
    Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
    Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
    Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
    Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
    PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
    Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
    J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
    Lan X; Jhaveri A; Cheng K; Wen H; Saleem MA; Mathieson PW; Mikulak J; Aviram S; Malhotra A; Skorecki K; Singhal PC
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F326-36. PubMed ID: 24899058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
    Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
    PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOL1 risk variants and the development of HIV-associated nephropathy.
    Goyal R; Singhal PC
    FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
    Hays T; Wyatt CM
    Kidney Int; 2012 Aug; 82(3):259-60. PubMed ID: 22791322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
    J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.
    Lan X; Wen H; Saleem MA; Mikulak J; Malhotra A; Skorecki K; Singhal PC
    Exp Mol Pathol; 2015 Jun; 98(3):491-501. PubMed ID: 25796344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
    Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
    Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tripartite complex of suPAR, APOL1 risk variants and α
    Hayek SS; Koh KH; Grams ME; Wei C; Ko YA; Li J; Samelko B; Lee H; Dande RR; Lee HW; Hahm E; Peev V; Tracy M; Tardi NJ; Gupta V; Altintas MM; Garborcauskas G; Stojanovic N; Winkler CA; Lipkowitz MS; Tin A; Inker LA; Levey AS; Zeier M; Freedman BI; Kopp JB; Skorecki K; Coresh J; Quyyumi AA; Sever S; Reiser J
    Nat Med; 2017 Aug; 23(8):945-953. PubMed ID: 28650456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
    Bruggeman LA; Wu Z; Luo L; Madhavan SM; Konieczkowski M; Drawz PE; Thomas DB; Barisoni L; Sedor JR; O'Toole JF
    J Am Soc Nephrol; 2016 Dec; 27(12):3600-3610. PubMed ID: 27026370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
    Kopp JB; Heymann J; Winkler CA
    Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From man to fish: What can Zebrafish tell us about ApoL1 nephropathy?
    Olabisi O; Al-Romaih K; Henderson J; Tomar R; Drummond I; MacRae C; Pollak M
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):114-118. PubMed ID: 27509583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
    Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
    Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.